Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Michael Wenke"'
Autor:
Rajat Kumar, Lilianne R. Mujica-Parodi, Michael Wenke, Anar Amgalan, Andrew Lithen, Sindhuja T. Govindarajan, Rany Makaryus, Helene Benveniste, Helmut H. Strey
Publikováno v:
Pharmaceutics, Vol 13, Iss 12, p 2069 (2021)
Substance abuse is a fundamentally dynamic disease, characterized by repeated oscillation between craving, drug self-administration, reward, and satiety. To model nicotine addiction as a control system, a magnetic resonance imaging (MRI)-compatible n
Externí odkaz:
https://doaj.org/article/d89e58a74e3c44e49cda5130f84b9804
Autor:
Elizabeth R. Gerstner, Julian He, Bruce R. Rosen, Michael Wenke, Pratik Talati, Eva-Maria Ratai, Tracy T. Batchelor, Melanie Fu, Anna Vaynrub, Ovidiu C. Andronesi, Isabel Arrillaga-Romany, Otto Rapalino, R. Gilberto Gonzalez, Mark Vangel, Mohamed El-Abtah, Akila Weerasekera, Daniel Kim, Jorg Dietrich, Yi-Fen Yen, Deborah Forst
Publikováno v:
Radiology
BACKGROUND: Patients with recurrent glioblastoma (GBM) are often treated with antiangiogenic agents, such as bevacizumab (BEV). Despite therapeutic promise, conventional MRI methods fail to help determine which patients may not benefit from this trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30b0db9c63f1076ce457eaca609cc689
https://pubmed.ncbi.nlm.nih.gov/34751617
https://pubmed.ncbi.nlm.nih.gov/34751617
Autor:
Suk-tak Chan, Nathaniel Mercaldo, Maria Gabriela Figueiro Longo, Jonathan Welt, Arman Avesta, Jacqueline Namati, Jarone Lee, Michael Lev, Eva-Maria Ratai, Michael Wenke, Blair Parry, Lynn Drake, Richard Anderson, Terry Rauch, Ramon Diaz-Arrastia, Kenneth Kwong, Michael Hamblin, Benjamin Vakoc, Rajiv Gupta
Recent studies demonstrate that low-level light therapy (LLLT) modulates recovery in patients with traumatic brain injury (TBI). However, the impact of LLLT on brain activity following TBI has not been well described. Here we use a randomized, double
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::907f661383e6d49df5ec175d22f2112c
https://doi.org/10.21203/rs.3.rs-2223939/v1
https://doi.org/10.21203/rs.3.rs-2223939/v1
Autor:
Elizabeth R. Gerstner, Bruce R. Rosen, Eva-Maria Ratai, Jorg Dietrich, Pratik Talati, Otto Rapalino, Deborah Forst, Ovidiu C. Andronesi, Sharif N Natheir, Jayashree Kalpathy-Cramer, Mark Vangel, Yi-Fen Yen, Daniel Kim, Ramon Gonzalez, Tracy T. Batchelor, Melanie Fu, Michael Wenke, Mohamed El-Abtah, Isabel Arrillaga-Romany, Julian He, Anna Vaynrub
Publikováno v:
Neuro Oncol
Patients with recurrent glioblastoma (rGBM) are often started on anti-angiogenic therapy such as bevacizumab. However, determining treatment failure using conventional MRI methods remains challenging. We prospectively collected longitudinal MR spectr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cb8db45e315a531dbf735719f5158d5
https://europepmc.org/articles/PMC8598661/
https://europepmc.org/articles/PMC8598661/
Autor:
Elizabeth R. Gerstner, Pratik Talati, Ramon Gonzalez, Otto Rapalino, Ovidiu C. Andronesi, Mark Vangel, Akila Weerasekera, Eva-Maria Ratai, Julian He, Daniel Kim, Yi-Fen Yen, Anna Vaynrub, Tracy T. Batchelor, Michael Wenke, Melanie Fu, Isabel Arrillaga-Romany, Jorg Dietrich, Bruce R. Rosen, Deborah Forst, Mohamed El-Abtah
Publikováno v:
Neuro Oncol
BACKGROUND Recurrent glioblastoma (rGBM) patients are often treated with anti-angiogenic agents such as bevacizumab (BEV). Despite therapeutic promise, conventional MR methods fail to determine which patients may not benefit. PURPOSE: The purpose of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c6c8c7cc44fc33d172a75a8a0a49d14
https://europepmc.org/articles/PMC8598526/
https://europepmc.org/articles/PMC8598526/
Autor:
Anna Vaynrub, Mark Vangel, Deborah Forst, Ovidiu C. Andronesi, Jayashree Kalpathy-Cramer, R. Gilberto Gonzalez, Eva-Maria Ratai, Mohamed El-Abtah, Julian He, Daniel Kim, Otto Rapalino, Tracy T. Batchelor, Michael Wenke, Bruce R. Rosen, Pratik Talati, Sharif N Natheir, Jorg Dietrich, Yi-Fen Yen, Elizabeth R. Gerstner, Melanie Fu, Isabel Arrillaga-Romany
Publikováno v:
Neuro-oncology Advances
Background Determining failure to anti-angiogenic therapy in recurrent glioblastoma (GBM) (rGBM) remains a challenge. The purpose of the study was to assess treatment response to bevacizumab-based therapy in patients with rGBM using MR spectroscopy (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b44a8edaebe403bceaa92b786de0297
https://doi.org/10.1093/noajnl/vdab060
https://doi.org/10.1093/noajnl/vdab060
Autor:
Andrew Lithen, Rany Makaryus, Sindhuja T. Govindarajan, Anar Amgalan, Helene Benveniste, Helmut H. Strey, Rajat Kumar, Michael Wenke, Lilianne R. Mujica-Parodi
BackgroundSubstance abuse is a fundamentally dynamic disease, characterized by repeated oscillation between craving, drug self-administration, reward, and satiety. To model nicotine addiction as a control system, an MR-compatible nicotine delivery sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be752899d41cfe9d29c69abf101f0a57
https://doi.org/10.1101/2020.09.17.302703
https://doi.org/10.1101/2020.09.17.302703